Vertical disintegration in the pharma industry and the role of IP
New business models are emergingin the pharmaceutical industry, so theway in which companies and serviceproviders in the sector handle IPissues is going to have to change
Download
-
-
News & Analysis
-
-
- Categories
- News & Analysis
- Long Reads
- Opinion
-
-
- Reports
-
Data & Tools
-
-
- Tools
- GTDT
-
-
Rankings
-
-
- IAM Patent 1000
- Introduction
- All Firms
- All Individuals
-
- IAM Strategy 300
- Introduction
- All individuals
-
- Global Leaders
- IAM Global Leaders
- Strategy 300 Global Leaders
-
- IAM Analytics
- Patent 1000 Analytics
-
-
-
Insight
-
-
- Hub
- SEP/FRAND
-
-
Events
-
-
- Events
- IAM & IPBC events
- Diary
-
-
-
- Login | Register